161 related articles for article (PubMed ID: 24686801)
1. Pseudohyponatraemia due to L-asparaginase-associated dyslipidaemia in T-cell lymphoblastic lymphoma.
Kothari J; Thomas A; Goldstone A
BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24686801
[No Abstract] [Full Text] [Related]
2. [Successful readministration of L-asparaginase after development of severe hypertriglyceridemia in a young adult with T-cell acute lymphoblastic leukemia].
Watanabe K; Yoshifuji K; Ohkawa R; Tozuka M; Miura O; Arai A
Rinsho Ketsueki; 2018; 59(12):2555-2560. PubMed ID: 30626788
[TBL] [Abstract][Full Text] [Related]
3. L-Asparaginase-associated hyperlipidemia with hyperviscosity syndrome in a patient with T-cell lymphoblastic lymphoma.
Meyer B; Hagen W; Scheithauer W; Ohler L; Kornek GV
Ann Oncol; 2003 Apr; 14(4):658-9. PubMed ID: 12649119
[No Abstract] [Full Text] [Related]
4. True hyponatremia in the setting of pegasparagase-induced hypertriglyceridemia: A case report.
Olayinka L; Poventud-Fuentes I; Rahman Ansari S; Garnett E; Devaraj S
Clin Chim Acta; 2022 Jun; 531():68-70. PubMed ID: 35283095
[TBL] [Abstract][Full Text] [Related]
5. Management of hypertriglyceridemia in children with acute lymphoblastic leukemia under persistent therapy with glucocorticoids and L-asparaginase during induction chemotherapy.
Salvador C; Meister B; Crazzolara R; Kropshofer G
Pediatr Blood Cancer; 2012 Oct; 59(4):771. PubMed ID: 22619026
[No Abstract] [Full Text] [Related]
6. Pegaspargase-induced hypertriglyceridemia in a patient with acute lymphoblastic leukemia.
Lau KM; Saunders IM; Goodman A
J Oncol Pharm Pract; 2020 Jan; 26(1):193-199. PubMed ID: 30823860
[TBL] [Abstract][Full Text] [Related]
7. Characterization of hypertriglyceridemia induced by L-asparaginase therapy for acute lymphoblastic leukemia and malignant lymphoma.
Tozuka M; Yamauchi K; Hidaka H; Nakabayashi T; Okumura N; Katsuyama T
Ann Clin Lab Sci; 1997; 27(5):351-7. PubMed ID: 9303174
[TBL] [Abstract][Full Text] [Related]
8. Treatment of severe hypertriglyceridemia associated with accidental pegylated asparaginase push in a child with relapsed acute lymphoblastic leukemia.
Malbora B; Avci Z; Ozbek N
Drug Chem Toxicol; 2012 Oct; 35(4):463-6. PubMed ID: 22149271
[TBL] [Abstract][Full Text] [Related]
9. L-asparaginase induced severe hypertriglyceridemia in acute lymphoblastic leukemia with 11q23 abnormality.
Jain S; Naithani R; Kapoor G; Nath T
Leuk Res; 2009 Nov; 33(11):e194. PubMed ID: 19487026
[No Abstract] [Full Text] [Related]
10. Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
Cohen H; Bielorai B; Harats D; Toren A; Pinhas-Hamiel O
Pediatr Blood Cancer; 2010 May; 54(5):703-6. PubMed ID: 20063421
[TBL] [Abstract][Full Text] [Related]
11. Successful management of extreme hypertriglyceridemia in a child with acute lymphoblastic leukemia by temporarily omitting dexamethasone while continuing asparaginase.
Tong WH; Pieters R; van der Sluis IM
Pediatr Blood Cancer; 2012 Feb; 58(2):317-8. PubMed ID: 22162400
[No Abstract] [Full Text] [Related]
12. Acarbose is an effective treatment for severe hypertriglyceridemia secondary to l-asparaginase and dexamethasone.
Tan M; Wai D; Chng CL; Hwang W
Leuk Lymphoma; 2012 Jun; 53(6):1245-6. PubMed ID: 22149169
[No Abstract] [Full Text] [Related]
13. l-asparaginase-induced biochemical toxicities in young adults with acute lymphoblastic leukaemia and T-lymphoblastic lymphoma.
Heenan JM; Hooper AJ; Burnett JR; Cooney J
Pathology; 2021 Dec; 53(7):924-926. PubMed ID: 34049714
[No Abstract] [Full Text] [Related]
14. L-Asparaginase and steroids-associated hypertriglyceridemia successfully treated with plasmapheresis in a child with acute lymphoblastic leukemia.
Solano-Páez P; Villegas JA; Colomer I; Gutierrez MD; Fernandez-Teijeiro A
J Pediatr Hematol Oncol; 2011 Apr; 33(3):e122-4. PubMed ID: 21399528
[TBL] [Abstract][Full Text] [Related]
15. Symptomatic severe hypertriglyceridaemia with asparaginase therapy in acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma: is rechallenging safe?
Lashkari HP; Lancaster D; Atra A; Champion MP; Taj MM
Int J Hematol; 2011 Dec; 94(6):571-5. PubMed ID: 22057510
[TBL] [Abstract][Full Text] [Related]
16. Desensitization to pegaspargase in children with acute lymphoblastic leukemia and lymphoblastic lymphoma.
August KJ; Farooki S; Fulbright JM; August A; Portnoy JM; Pommert L; Burke MJ; Guest EM
Pediatr Blood Cancer; 2020 Jan; 67(1):e28021. PubMed ID: 31571395
[TBL] [Abstract][Full Text] [Related]
17. Severe hypertriglyceridemia during treatment of acute lymphoblastic leukemia associated with type III hyperlipoproteinemia.
Yamada Y; Shima H; Shibata H; Ishii T; Hasegawa T; Shimada H
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28371240
[No Abstract] [Full Text] [Related]
18. Transient hyperthyroidism following L-asparaginase therapy for acute lymphoblastic leukemia.
Fadilah SA; Faridah I; Cheong SK
Med J Malaysia; 2000 Dec; 55(4):513-5. PubMed ID: 11221167
[TBL] [Abstract][Full Text] [Related]
19. L-asparaginase induced acute parotitis during intensification therapy of acute lymphoblastic leukemia.
Kathwate J; Mundada S; Patil P
Indian J Cancer; 2014; 51(4):537. PubMed ID: 26842187
[No Abstract] [Full Text] [Related]
20. L-asparaginase induced hypoglycemia in a case of acute lymphoblastic leukemia: a patient report.
Misgar RA; Laway BA; Rahaman SH; Wani AI; Bashir MI; Bhat JR
J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):439-41. PubMed ID: 25210761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
